Personality-targeted prevention for adolescent tobacco use: Three-year outcomes for a randomised trial in Australia

被引:7
|
作者
Debenham, Jennifer [1 ]
Grummitt, Lucinda [1 ]
Newton, Nicola Clare [1 ]
Teesson, Maree [1 ]
Slade, Tim [1 ]
Conrod, Patricia [2 ,3 ]
Kelly, Erin Veronica [1 ]
机构
[1] Univ Sydney, Matilda Ctr Res Mental Hlth & Substance Use, Level 6, Sydney, NSW, Australia
[2] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada
[3] Kings Coll London, Inst Psychiat, London, England
基金
英国医学研究理事会;
关键词
Tobacco; Young people; Personality-targeted; Prevention; School; RISK PROFILE SCALE; SUBSTANCE USE; ANXIETY SENSITIVITY; ALCOHOL-USE; SMOKING; INTERVENTIONS; EXPECTANCIES; DEPENDENCE; UNIVERSAL; EFFICACY;
D O I
10.1016/j.ypmed.2021.106794
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This is the first study to investigate the effectiveness of Preventure, a selective personality-targeted prevention program, in reducing the uptake of tobacco smoking over a three-year period in adolescence. A cluster randomised controlled trial was conducted to assess the effectiveness of Preventure. Schools were block randomised to either the Preventure group (n = 7 schools) or the Control group (n = 7 schools) and students were assessed at five time points (baseline, 6-, 12-, 24-and 36-months post-baseline) on measures of tobacco use, intentions to use and self-efficacy to resist peer pressure to smoke tobacco. Intervention effects were estimated using mixed models to account for the hierarchical data structure. Exploratory analyses assessed intervention effects among internalising and externalising personality traits. This trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12612000026820; www.anzctr.org.au). A total of 1005 adolescents (mean age: 13.4 years, SD = 0.47) attending 14 Australian schools in February 2012 were recruited to the study. Relative to students in Control schools, students in Preventure schools were less likely to report recent tobacco use (OR = 0.66 95% CI = 0.50, 0.87) and intentions to use tobacco in the future (OR = 0.77 95% CI = 0.60, 0.97) over the three-year follow-up. Students in Preventure schools with internalising personality traits had a greater increase in their likelihood to report high self-efficacy to resist peer pressure to smoke sustained three-years post program delivery (OR = 1.85 95% CI = 1.0, 3.4). Findings from this study support the use of selective personality-targeted preventive interventions in reducing tobacco smoking during adolescence.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy
    Khalafallah, Alhossain A.
    Dennis, Amanda E.
    Ogden, Kath
    Robertson, Iain
    Charlton, Ruth H.
    Bellette, Jackie M.
    Shady, Jessica L.
    Blesingk, Nep
    Ball, Madeleine
    [J]. BMJ OPEN, 2012, 2 (05):
  • [42] Type 2 Diabetes Prevention in the Real World Three-year results of the GOAL Lifestyle Implementation Trial
    Absetz, Pilvikki
    Oldenburg, Brian
    Hankonen, Nelli
    Valve, Raisa
    Heinonen, Heikki
    Nissinen, Aulikki
    Fogelholm, Mikael
    Talja, Martti
    Uutela, Antti
    [J]. DIABETES CARE, 2009, 32 (08) : 1418 - 1420
  • [43] Two-Year Outcomes of a Randomized, Family-Based Substance Use Prevention Trial for Asian American Adolescent Girls
    Fang, Lin
    Schinke, Steven P.
    [J]. PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2013, 27 (03) : 788 - 798
  • [44] The school-led Preventure study: Protocol of a cluster-randomised controlled trial of effectiveness to prevent adolescent alcohol misuse, internalising problems, and externalising problems through a personality-targeted intervention delivered by school staff
    Kelly, Erin Veronica
    Grummitt, Lucinda Rachel
    Birrell, Louise
    Stapinski, Lexine
    Barrett, Emma Louise
    Boyle, Julia
    Teesson, Maree
    Newton, Nicola Clare
    [J]. PREVENTIVE MEDICINE REPORTS, 2021, 21
  • [45] Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion Three-Year Randomized DAVE Trial
    Brown, David M.
    Ou, William C.
    Wong, Tien P.
    Kim, Rosa Y.
    Croft, Daniel E.
    Wykoff, Charles C.
    [J]. OPHTHALMOLOGY, 2018, 125 (05) : 683 - 690
  • [46] Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial
    Gilling, Peter
    Barber, Neil
    Bidair, Mohamed
    Anderson, Paul
    Sutton, Mark
    Aho, Tev
    Kramolowsky, Eugene
    Thomas, Andrew
    Cowan, Barrett
    Kaufman, Ronald P., Jr.
    Trainer, Andrew
    Arther, Andrew
    Badlani, Gopal
    Plante, Mark
    Desai, Mihir
    Doumanian, Leo
    Te, Alexis E.
    DeGuenther, Mark
    Roehrborn, Claus
    [J]. CANADIAN JOURNAL OF UROLOGY, 2020, 27 (01) : 10072 - 10079
  • [47] Three-year outcomes of sirolimus-eluting stents for the treatment of in-stent restenosis: The SISR trial
    Holmes, David
    Popma, Jeffrey
    Fitzgerald, Peter
    Tierstein, Paul
    Seller, Lowell
    Sketch, Michael
    Cohen, Sidney
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B7 - B7
  • [48] Three-year outcomes of the postapproval study of the AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation Trial
    McCarthy, Patrick M.
    Gerdisch, Marc
    Philpott, Jonathan
    Barnhart, Glenn R.
    Waldo, Albert L.
    Shemin, Richard
    Andrei, Adin-Cristian
    Gaynor, Sydney
    Ndikintum, Nfii
    Calkins, Hugh
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (02): : 519 - +
  • [49] Three-year randomised clinical trial to evaluate the clinical performance, quantitative and qualitative wear patterns of hybrid composite restorations
    Palaniappan, Senthamaraiselvi
    Elsen, Liesbeth
    Lijnen, Inge
    Peumans, Marleen
    Meerbeek, Bart Van
    Lambrechts, Paul
    [J]. CLINICAL ORAL INVESTIGATIONS, 2010, 14 (04) : 441 - 458
  • [50] Some methodologic issues in analyzing data from a randomized adolescent tobacco and alcohol use prevention trial
    Slymen, DJ
    Elder, JP
    Litrownik, AJ
    Ayala, GX
    Campbell, NR
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (04) : 332 - 340